This study also reported that ATF5 is responsible for the transactivation of BCL-2 via an ATF5-specific regulatory element, and that this is predominantly responsible for the cell-type dependent antiapoptotic function of ATF5 in breast cancer. The gene discussed is ATF5; the disease is breast cancer.